**Core Concept**
Gestational trophoblastic diseases (GTDs) are a group of rare tumors that arise from the placenta during pregnancy. Prophylaxis of GTDs is crucial to prevent the development of these life-threatening conditions. The most effective drug used for prophylaxis of GTDs is one that targets the underlying pathophysiology of the disease.

**Why the Correct Answer is Right**
The correct answer, **Methotrexate**, is an antifolate drug that inhibits dihydrofolate reductase (DHFR), an enzyme essential for DNA synthesis and cell division. By blocking DHFR, methotrexate prevents the proliferation of abnormal trophoblastic cells, thereby reducing the risk of GTDs. This mechanism is particularly effective in preventing the development of GTDs in high-risk patients, such as those with a history of previous GTDs or those with multiple gestations.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specifically target the pathophysiology of GTDs. **Option B:** This option is incorrect because it is not commonly used for prophylaxis of GTDs. **Option D:** This option is incorrect because it is not effective in preventing the development of GTDs.

**Clinical Pearl / High-Yield Fact**
Methotrexate is also used in the treatment of ectopic pregnancies, another condition related to abnormal trophoblastic cell proliferation. It is essential to note that methotrexate should be used under close medical supervision due to its potential side effects and interactions with other medications.

**Correct Answer:** A. Methotrexate